It relied on their self-assessment to gauge improvement and didnt compare the group that received the peptide to one that did not
Show notes Clinical Implementation of GLP-1 Receptor Agonists What were the groundbreaking findings of the STEP1 and SURMOUNT-1 trials and how these impact cardiovascular wellness
Dilalla, V., Chaput, G., Williams, T
However, its worth noting that what counts as a microdose for one person may be a standard starting dose for another
While many of the drug manufacturers, as well as the various compounding pharmacies**, continue to promote and make superfluous claims on all the health benefits of GLP-1 medications, consumers need to be aware of the downsides
Your RescueMD provider will set individualized goals